Skip to content
监管与产业动态· FierceBiotech·· 20 hours agoScore54

Lilly partners with Hong Kong's Metis in $1.1B deal to bolster AI nanoparticle discovery - Fierce Biotech

In brief

Lilly has entered a collaboration totaling $1.1 billion with Hong Kong-based Metis, focused on using AI to accelerate nanoparticle discovery. Only headline-level details were disclosed; no breakdown of upfront payments, milestones, research directions, or indications was given.

Source: 监管与产业动态

CBACBA Frontier Insights (CFI)Chinese Biopharmaceutical Association (CBA)www.cba-usa.org